SSG
NVAX icon

Summit Securities Group’s Novavax NVAX Stock Holding History

Summit Securities Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,000
Closed -$269K – 1278
2025
Q4 		$269K Hold
40,000
– – 0.04% 279
2025
Q3 		$347K Hold
40,000
– – 0.07% 201
2025
Q2 		$252K Buy
+40,000
New +$265K 0.05% 222
2022
Q1 		– Sell
-1,200
Closed -$172K – 1273
2021
Q4 		$172K Buy
+1,200
New +$206K 0.01% 632
2021
Q3 		– Sell
-10
Closed -$212K – 834
2021
Q2 		$212K Buy
+10
New +$1.83K 0.02% 644

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Securities Group's NVAX Position: Q4 2024 in Review

Summit Securities Group sold out of Novavax (NVAX) in Q4 2024, closing a stake of 337 shares — an estimated $4K sold.

Summit Securities Group first reported a position in NVAX in Q3 2024 and held it in 1 quarter. The position peaked at $4K in Q3 2024. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Summit Securities Group reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Summit Securities Group sold 337 Novavax shares in Q4 2024, an estimated $4K.
  • Summit Securities Group first reported a position in Novavax in Q3 2024 and held it in 1 quarter.
  • Summit Securities Group's Novavax position peaked at $4K in Q3 2024.
  • 234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Summit Securities Group's 13F filing for Q4 2024, filed 12 Feb 2025.